Product Specification
Host |
Rabbit |
Antigen |
Vimentin |
Immunogen |
Synthetic Peptide |
Accession |
P08670 |
Clone Number |
SDT-029-20 |
Antibody Type |
Rabbit mAb |
Isotype |
IgG |
Application |
WB, IHC-P, ICC, IF |
Reactivity |
Hu, Ms, Rt |
Predicted Reactivity |
Pr, Bv, Cz, Pg, Hm, Av |
Purification |
Protein A |
Research Area |
Neuroscience |
Concentration |
1 mg/ml |
Molecular Weight |
56kDa |
Conjugation |
Unconjugated |
Physical Appearance |
Liquid |
Storage Buffer |
PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300 |
Stability & Storage |
12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application |
dilution |
species |
WB |
1:1000 |
|
IHC-P |
1:1000 |
|
ICC |
1:200 |
|
IF |
1:200 |
|
Background
Vimentin is a structural protein that in humans is encoded by the VIM gene. Vimentin is a type III intermediate filament (IF) protein that is expressed in mesenchymal cells. IF proteins are found in all animal cells as well as bacteria. Intermediate filaments, along with tubulin-based microtubules and actin-based microfilaments, comprises the cytoskeleton. All IF proteins are expressed in a highly developmentally-regulated fashion; vimentin is the major cytoskeletal component of mesenchymal cells. Because of this, vimentin is often used as a marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal transition (EMT) during both normal development and metastatic progression.